CABG surgery, but not PCI, is a cost-effective treatment for coronary disease
This article has no abstract so we have provided the first paragraph of the full text.
Medical management, percutaneous coronary intervention (PCI) and CABG surgery are all viable therapeutic strategies for coronary disease. The choice between these methods is made largely on the basis of clinical appropriateness. Griffin et al. carried out a 6-year prospective observational study to investigate whether, when judged clinically appropriate, these treatments are also cost-effective.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
